| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $619.4M | +23.1% |
| Cost of Revenue | $609.0M | +31.9% |
| R&D Expense | $648.3M | +17.5% |
| SG&A Expense | $704.4M | +17.4% |
| Pre-tax Income | $525.9M | +125.4% |
| Income Tax | $44.5M | +116.8% |
| Net Income | $481.3M | -3.5% |
| EPS (Basic) | $0.42 | -8.7% |
| EPS (Diluted) | $0.39 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.93B | +94.2% |
| Total Assets | $50.66B | +39.7% |
| Total Liabilities | $40.17B | +35.1% |
| Stockholders' Equity | $10.49B | +60.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.74B | -234.2% |
| Investing Cash Flow | -$6.72B | -39.4% |
| Financing Cash Flow | $13.11B | +160.4% |
| +0.0% |